(Q36885714)

16 August 2017

1 reference

title

Standard and low-dose hormone therapy for postmenopausal women--focus on the breast (English)

1 reference

16 August 2017

Peng-Hui Wang

1

1 reference

16 August 2017

Huann-Cheng Horng

2

1 reference

16 August 2017

Ming-Huei Cheng

3

1 reference

16 August 2017

Hsiang-Tai Chao

4

1 reference

16 August 2017

Kuan-Chong Chao

5

1 reference

16 August 2017

publication date

1 June 2007

1 reference

Taiwanese Journal of Obstetrics & Gynecology

16 August 2017

published in

1 reference

16 August 2017

volume

46

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

127-134

1 reference

Effects of tibolone on the breast of postmenopausal women

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Hormones and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Breast cancer risk with postmenopausal hormonal treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Benefits and risks of long-term low-dose oral continuous combined hormone therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Classification and pharmacology of progestins

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Progestins in the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Libido: the biologic scenario

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Pharmacological profile of progestins

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Transdermal hormone therapy: gels and patches

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Low-dose estrogen therapy for menopausal women: a review of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Breast cancer and hormone-replacement therapy: the Million Women Study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Pathophysiology and treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

The efficacy of two dosages of a continuous combined hormone replacement regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Postmenopausal hormone therapy and change in mammographic density

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Mammographic density changes during different postmenopausal hormone replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

The effect of low dose hormone therapy on mammographic breast density.

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

Influence of different HRT regimens on mammographic density

1 reference

https://api.crossref.org/works/10.1016%2FS1028-4559%2807%2960006-0

7 January 2021

10.1016/S1028-4559(07)60006-0

Identifiers

DOI

1 reference

16 August 2017

1 reference